Reply to comments on: “Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn’s disease—A prospective nationwide multicenter cohort study”
Wiener klinische Wochenschrift · 2024
DOI: 10.1007/s00508-024-02363-z ↗Kurz gefasst
Leserbrief in der Zeitschrift Wiener klinische Wochenschrift, 2024. Verfasst von Stefan Riss und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Medical University Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. stefan.riss@meduniwien.ac.at. Hauptthemen laut MEDLINE: Crohn Disease, Rectal Fistula. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of General Surgery, Medical University Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. stefan.riss@meduniwien.ac.at.
- Department of General Surgery, Medical University Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Zitieren
APA
Riss, S., & Dawoud, C. (2024). Reply to comments on: “Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn’s disease—A prospective nationwide multicenter cohort study”. Wiener klinische Wochenschrift. https://doi.org/10.1007/s00508-024-02363-z
Vancouver
Riss S, Dawoud C. Reply to comments on: “Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn’s disease—A prospective nationwide multicenter cohort study”. Wiener klinische Wochenschrift. 2024. doi:10.1007/s00508-024-02363-z
BibTeX
@article{Riss2024,
author = {Riss, Stefan and Dawoud, Christopher},
title = {Reply to comments on: “Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn’s disease—A prospective nationwide multicenter cohort study”},
journal = {Wiener klinische Wochenschrift},
year = {2024},
doi = {10.1007/s00508-024-02363-z}
}
EUVIMED